BYOMass

Origo Biopharma

This clinical-stage biotechnology company develops small molecule therapies targeting the transforming growth factor beta pathway to treat fibrosis and cancer in healthcare patients.

BioAge Labs

This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.

OMass Therapeutics

This company develops small molecule therapeutics for patients with immunological and rare diseases using a proprietary native mass spectrometry platform.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.

Keros

This company develops therapeutics for patients with hematological, pulmonary and cardiovascular disorders linked to dysfunctional signalling of the transforming growth factor-beta protein family.

Fable Therapeutics

The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.

Granite Bio

This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.

Graviton Bioscience Corporation

The company develops small-molecule therapeutics targeting autoimmune, fibrotic and central nervous system diseases for patients with unmet medical needs.